Publisher: Wiley-Blackwell

Related content
Volume 22, Number 2, February 2005

< previous issue | all issues | next issue >

Favourites:Add to Favourites
Favourites:Add to Favourites

Insulin treatment and cardiovascular disease; friend or foe? A point of view
pp. 118-126(9)
Authors: Muis, M. J.; Bots, M. L.; Grobbee, D. E.; Stolk, R. P.

Favourites:Add to Favourites

Clinical characteristics, β-cell function, HLA class II and mutations in MODY genes in non-paediatric subjects with Type 1 diabetes without pancreatic autoantibodies
pp. 137-143(7)
Authors: Aguilera, E.; Casamitjana, R.; Ercilla, G.; Oriola, J.; Nicoletti, F.; Gomis, R.; Conget, I.

Favourites:Add to Favourites
Favourites:Add to Favourites

Psychiatric morbidity and health outcome in Type 1 diabetes – perspectives from a prospective longitudinal study
pp. 152-157(6)
Authors: Northam, E. A.; Matthews, L. K.; Anderson, P. J.; Cameron, F. J.; Werther, G. A.

Favourites:Add to Favourites

Effects of nateglinide on myocardial microvascular reactivity in Type 2 diabetes mellitus – a randomized study using positron emission tomography
pp. 158-163(6)
Authors: Bengel, F. M.; Abletshauser, C.; Neverve, J.; Schnell, O.; Nekolla, S. G.; Standl, E.; Schwaiger, M.

Favourites:Add to Favourites

Healing diabetic neuropathic foot ulcers: are we getting better?
pp. 172-176(5)
Authors: Margolis, D. J.; Allen-Taylor, L.; Hoffstad, O.; Berlin, J. A.

Favourites:Add to Favourites

Unchanged incidence of diabetic nephropathy in Type 1 diabetes: a nation-wide study in Iceland
pp. 182-187(6)
Authors: Tryggvason, G.; Indridason, O. S.; Thorsson, A. V.; Hreidarsson, A. B.; Palsson, R.

Favourites:Add to Favourites

NT-proBNP in normoalbuminuric patients with Type 2 diabetes mellitus
pp. 188-195(8)
Authors: Andersen, N. H.; Poulsen, S. H.; Knudsen, S. T.; Heickendorff, L.; Mogensen, C. E.

Favourites:Add to Favourites

Interclinician variation in diabetes foot assessment— a national lottery?
pp. 196-199(4)
Authors: Thompson, L.; Nester, C.; Stuart, L.; Wiles, P.

Favourites:Add to Favourites

Controlling the diabetes epidemic: how should we screen for undiagnosed diabetes and dysglycaemia?
pp. 207-212(6)
Authors: Simmons, D.; Thompson, C. F.; Engelgau, M. M.

Favourites:Add to Favourites

Glycaemic and insulin responses of six traditional Sudanese carbohydrate-rich meals in subjects with Type 2 diabetes mellitus
pp. 213-217(5)
Authors: Abdelgadir, M.; Abbas, M.; Järvi, A.; Elbagir, M.; Eltom, M.; Berne, C.

Favourites:Add to Favourites
Favourites:Add to Favourites

Near patient blood ketone measurements and their utility in predicting diabetic ketoacidosis
pp. 221-224(4)
Authors: Harris, S.; Ng, R.; Syed, H.; Hillson, R.

Favourites:Add to Favourites

Insulin resistance determines efficacy of glimepiride in Type 2 diabetic patients not well controlled by diet alone
pp. 225-226(2)
Authors: Shimizu, Hiroyuki; Monden, Takeshi; Nagai, Takashi; Shoda, Yoshihito; Sato, Tetsurou; Yamada, Masanobu; Mori, Masatomo

Favourites:Add to Favourites

Regarding the use of HOMA to aid drug selection
pp. 225-225(1)
Author: Richards, R. J.

Favourites:Add to Favourites

A deletion polymorphism of the α2B-adrenergic receptor gene is not associated with late complications in Type 1 diabetic patients
pp. 226-228(3)
Authors: Heinonen, P.; Pettersson-Fernholm, K.; Forsblom, C.; Kallio, J.; Scheinin, M.; Groop, P.-H.

Favourites:Add to Favourites

Framingham risk equations underestimate coronary heart disease risk in diabetes
pp. 228-228(1)
Authors: Stevens, R. J.; Coleman, R. L.; Holman, R. R.

Favourites:Add to Favourites

Diabetic Medicine diary
pp. 229-229(1)

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more